Zobrazeno 1 - 10
of 198
pro vyhledávání: '"J, Smeenk"'
Autor:
Niven Mehra, Iris Kloots, Michiel Vlaming, Shafak Aluwini, Els Dewulf, Daniela E. Oprea-Lager, Henk van der Poel, Herman Stoevelaar, Derya Yakar, Chris H. Bangma, Elise Bekers, Roderick van den Bergh, Andries M. Bergman, Franchette van den Berkmortel, Steve Boudewijns, Winand N.M. Dinjens, Jurgen Fütterer, Tom van der Hulle, Guido Jenster, Leonie I. Kroeze, Michel van Kruchten, Geert van Leenders, Pim J. van Leeuwen, Wendy W.J. de Leng, R. Jeroen A. van Moorselaar, Walter Noordzij, Rogier A. Oldenburg, Inge M. van Oort, Irma Oving, Jack A. Schalken, Ivo G. Schoots, Ed Schuuring, Robert J. Smeenk, Ben G.L. Vanneste, Erik Vegt, André N. Vis, Kim de Vries, Peter-Paul M. Willemse, Maurits Wondergem, Margreet Ausems
Publikováno v:
European Urology Open Science, Vol 49, Iss , Pp 23-31 (2023)
Background: Germline and tumour genetic testing in prostate cancer (PCa) is becoming more broadly accepted, but testing indications and clinical consequences for carriers in each disease stage are not yet well defined. Objective: To determine the con
Externí odkaz:
https://doaj.org/article/6f52ae4fdd99475585e6ab93b18449bb
Autor:
Rik van den Elshout, Tom W. J. Scheenen, Chantal M. L. Driessen, Robert J. Smeenk, Frederick J. A. Meijer, Dylan Henssen
Publikováno v:
Insights into Imaging, Vol 13, Iss 1, Pp 1-12 (2022)
Abstract Background In a considerable subgroup of glioma patients treated with (chemo) radiation new lesions develop either representing tumor progression (TP) or treatment-related abnormalities (TRA). Quantitative diffusion imaging metrics such as t
Externí odkaz:
https://doaj.org/article/543d49da118e4ca49969e42643b81e5e
Autor:
J. Janssen, F. H. E. Staal, C. L. Brouwer, J. A. Langendijk, I. J. de Jong, R. J. A. van Moorselaar, E. Schuit, J. F. Verzijlbergen, R. J. Smeenk, S. Aluwini
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background More than 60% of oligo-recurrent prostate cancer (PCa) patients treated with metastasis-directed radiotherapy (MDRT) develop biochemical recurrence within 2 years. This recurrence rate emphasises the need for improved treatment an
Externí odkaz:
https://doaj.org/article/55e4ffe7575643bcb0888b739ecc5219
Autor:
F. H. E. Staal, J. Janssen, C. L. Brouwer, J. A. Langendijk, K. Ng Wei Siang, E. Schuit, I. J. de Jong, J. F. Verzijlbergen, R. J. Smeenk, S. Aluwini
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Highlights • This is the first PSMA PET/CT based study addressing the role of hypofractionation in salvage external beam radiation therapy (sEBRT); • Participants will be randomised 1:1 to conventional fractionated sEBRT (35 × 2 Gy) or hypofract
Externí odkaz:
https://doaj.org/article/3d139f669a3c4444b20080136b2b7478
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 29, Iss , Pp 40-46 (2021)
Background and purpose: For irradiation of localized prostate-cancer, moderately-hypofractionated regimens with a variety of dose per fraction are used. We adopted a regimen of 70 Gy in 28 fractions of 2.5 Gy, using state of the art radiotherapy (RT)
Externí odkaz:
https://doaj.org/article/c7b4c093594b4e7bbace757fcddd30cc
Autor:
Marie-Christina Jahreiß, Wilma D. Heemsbergen, Bo van Santvoort, Mischa Hoogeman, Maarten Dirkx, Floris J. Pos, Tomas Janssen, Andre Dekker, Ben Vanneste, Andre Minken, Carel Hoekstra, Robert J. Smeenk, Inge M. van Oort, Chris H. Bangma, Luca Incrocci, Katja K. H. Aben
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
PurposeExternal Beam Radiotherapy (EBRT) techniques dramatically changed over the years. This may have affected the risk of radiation-induced second primary cancers (SPC), due to increased irradiated low dose volumes and scatter radiation. We investi
Externí odkaz:
https://doaj.org/article/e94401e37f50411fad083642701633c0
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
N. E. van Hoogenhuijze, H. L. Torrance, F. Mol, J. S. E. Laven, E. Scheenjes, M. A. F. Traas, C. Janssen, B. Cohlen, G. Teklenburg, J. P. de Bruin, R. van Oppenraaij, J. W. M. Maas, E. Moll, K. Fleischer, M. H. van Hooff, C. de Koning, A. Cantineau, C. B. Lambalk, M. Verberg, M. Nijs, A. P. Manger, M. van Rumste, L. F. van der Voet, A. Preys-Bosman, J. Visser, E. Brinkhuis, J. E. den Hartog, A. Sluijmer, F. W. Jansen, W. Hermes, M. L. Bandell, M. J. Pelinck, J. van Disseldorp, M. van Wely, J. Smeenk, Q. D. Pieterse, J.C. Boxmeer, E.R. Groenewoud, M. J. C. Eijkemans, J. C. Kasius, F. J. M. Broekmans
Publikováno v:
BMC Women's Health, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background Success rates of assisted reproductive techniques (ART) are approximately 30%, with the most important limiting factor being embryo implantation. Mechanical endometrial injury, also called ‘scratching’, has been proposed to po
Externí odkaz:
https://doaj.org/article/749869bdb9e5483aa745d2584ff88a54
Autor:
Eva M E Balkenende, Taghride Dahhan, Catharina C M Beerendonk, Kathrin Fleischer, Dominic Stoop, Annelies M E Bos, Cornelis B Lambalk, Roel Schats, Jesper M J Smeenk, Leonie A Louwé, Astrid E P Cantineau, Jan Peter de Bruin, Sabine C Linn, Fulco van der Veen, Madelon van Wely, Mariëtte Goddijn
Publikováno v:
Human reproduction (Oxford, England), 37(8), 1786-1794. Oxford University Press
Balkenende, E M E, Dahhan, T, Beerendonk, C C M, Fleischer, K, Stoop, D, Bos, A M E, Lambalk, C B, Schats, R, Smeenk, J M J, Louwé, L A, Cantineau, A E P, de Bruin, J P, Linn, S C, van der Veen, F, van Wely, M & Goddijn, M 2022, ' Fertility preservation for women with breast cancer : a multicentre randomized controlled trial on various ovarian stimulation protocols ', Human reproduction (Oxford, England), vol. 37, no. 8, pp. 1786-1794 . https://doi.org/10.1093/humrep/deac145
HUMAN REPRODUCTION
Human Reproduction, 37(8), 1786-1794. OXFORD UNIV PRESS
Balkenende, E M E, Dahhan, T, Beerendonk, C C M, Fleischer, K, Stoop, D, Bos, A M E, Lambalk, C B, Schats, R, Smeenk, J M J, Louwé, L A, Cantineau, A E P, de Bruin, J P, Linn, S C, van der Veen, F, van Wely, M & Goddijn, M 2022, ' Fertility preservation for women with breast cancer : a multicentre randomized controlled trial on various ovarian stimulation protocols ', Human reproduction (Oxford, England), vol. 37, no. 8, pp. 1786-1794 . https://doi.org/10.1093/humrep/deac145
HUMAN REPRODUCTION
Human Reproduction, 37(8), 1786-1794. OXFORD UNIV PRESS
STUDY QUESTION Does ovarian stimulation with the addition of tamoxifen or letrozole affect the number of cumulus-oocyte complexes (COCs) retrieved compared to standard ovarian stimulation in women with breast cancer who undergo fertility preservation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::13da2158eecf06e12777bc879171759b
https://research.rug.nl/en/publications/2704118c-bab7-45a6-aaf7-b5ed43ce9b9c
https://research.rug.nl/en/publications/2704118c-bab7-45a6-aaf7-b5ed43ce9b9c
Autor:
James Nagarajah, J. Alfred Witjes, Martin Gotthardt, Jelle O. Barentsz, Sandra Heskamp, Jean-Paul A. van Basten, Diederik M. Somford, Robert J. Smeenk, Linda G.W. Kerkmeijer, Niven Mehra, Winald R. Gerritsen, J. Fred Verzijlbergen, Tom W.J. Scheenen, Annemarie Eek, Melline G.M. Schilham, Maike J.M. Uijen, Patrik Zámecnik, Mark W. Konijnenberg, J.P. Michiel Sedelaar, Marcel J.R. Janssen, Inge M. van Oort, Constantijn H.J. Muselaers, Steffie M.B. Peters, Bastiaan M. Privé
Purpose:[177Lu]Lu-PSMA-617 radioligand therapy (177Lu-PSMA) is a novel treatment for metastatic castration-resistant prostate cancer (mCRPC), which could also be applied to patients with metastatic hormone-sensitive prostate cancer (mHSPC) with PSMA
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ee5227f2482c2e8c0f3bed1c1ab3d53
https://doi.org/10.1158/1078-0432.c.6530696.v1
https://doi.org/10.1158/1078-0432.c.6530696.v1
